Bagsværd, Denmark Saturday, September 21, 2024, 15:00 Hrs [IST] ...

For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...

When surveyed, many physicians said the belief that patients had adequate symptom control was why they didn’t add more meds.

EMA endorses Novo Nordisk's Wegovy for treating heart failure and lowering heart risks in obese patients. Second approval ...

For patients with heart failure with preserved ejection fraction (HFpEF), endovascular treatment (EVT) improves left ...

Novo Nordisk receives a positive opinion from the CHMP for a label update of Wegovy to reflect reduced heart failure symptoms ...

The trial results indicated minimal adverse events and no evidence of immune-mediated clearance following TX45 treatment.

Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD, discuss the use of beta-blocker therapy following acute MI ...